Control of bovine respiratory disease, with and without co-morbidity by otitis media, in dairy heifers comparing gamithromycin, tulathromycin, or no medication at a commercial development facility

The objective of this study was to evaluate one strategy for control (metaphylaxis) of bovine respiratory disease, with and without co-morbidity with otitis media, in dairy heifers at a commercial development facility. Individual heifers were the experimental unit. At weaning, 1 of 3 experimental treatments (gamithromycin, tulathromycin, or no medication) was randomly assigned to 1,567 heifers from 11 different dairies. Gamithromycin was administered to 631 heifers, tulathromycin was administered to 621 heifers, and no medication was administered to 315 heifers (negative control). Heifers were then commingled and penned according to body weight. Each pen contained heifers from each group, and periodically, larger numbers of heifers were penned together. All heifers were observed for the subsequent 42 d and treated according to protocols prescribed for the facility. Morbidity due to respiratory disease was less for heifers medicated with gamithromycin than for heifers medicated with tulathromycin. Morbidity due to respiratory disease was less for heifers medicated with gamithromycin than for heifers in the negative control group. Fewer heifers medicated with either antimicrobial were subsequently treated because of co-morbidity with otitis media. Mortality was not different among the treatment groups. Heifers medicated with either antimicrobial had greater average daily gain than did heifers in the negative control group.